E.1 Depression PowerPoint 20151
E.1 Depression PowerPoint 20151
E.1 Depression PowerPoint 20151
Chapter E.1
Depression
in Children
and
Adolescents
Joseph M Rey, Tolulope T Bella-
Awusah & Jing Liu
DEPRESSION IN CHILDREN AND
ADOLESCENTS
Please note that this book and its companion powerpoint are:
· Free and no registration is required to read or download it
· This is an open-access publication under the Creative Commons Attribution Non-
commercial License. According to this, use, distribution and reproduction in any
medium are allowed without prior permission provided the original work is
properly cited and the use is non-commercial.
• Definition
• Epidemiology
• Age of Onset and Course
• Subtypes of Depression
• Etiology and Risk Factors
• Comorbidity
• Diagnosis
• Differential Diagnosis
• Rating Scales
• Treatment
• Cross Cultural Perspectives
• Barriers to Care
• Prevention
• Definition
• Core symptoms
• Associated symptoms
• Variations
• Appropriate terms
Depression in Children and Adolescents
Epidemiology
• Pre-pubertal children: 1-2%
• Adolescents: 5%
• Cumulative prevalence
– Girls: 12%
– Boys: 7%
Depression in Children and Adolescents
Subtypes
• Catatonic depression • Unipolar depression
• Post-psychotic • Bipolar depression
depression • Psychotic depression
• Premenstrual dysphoric • Melancholic depression
disorder • Dysthymic disorder
• Seasonal depression • Double depression
• Mood disorder NOS
• Adjustment disorder
with depressed mood
• Minor depression
Depression in Children and Adolescents
Etiology
• Genetics
• Prenatal factors
• Family relationships
• Parental depression*
• Cognitive style
• Stressful life events
• Lack of parental care
• Anxiety disorders
• Post Traumatic Stress Disorder
• Conduct problems
• Attention Deficit Hyperactivity Disorder
• Obsessive Compulsive Disorder
• Learning difficulties
• Suicidal thoughts:
– 1/6 girls
– 1/10 boys
• 100:1 ratio of attempts to completions
• 60% depressed youth have thoughts of suicide
• 30% depressed youth make a suicide attempt
• Risk factors: family history, previous attempts,
comorbidities, aggression, impulsivity, access to lethal
means, negative life events
• Core symptoms
• Associated symptoms
• Pervasiveness
• Duration
• Impairment or distress
http://www.abc.net.au/austory/specials/leastlikely/
• Medications
• Substances of abuse
• Infections
• Neurological disorders
• Endocrine
• Unipolar vs. bipolar
• Psychotic depression vs. schizophrenia
• Depression vs. substance use
• Depression vs. adjustment disorder with
depressed mood
• Depression vs. demoralization from disruptive
disorders
• CES-DC: Center for Epidemiologic Studies-Depression
Scale
• MFQ: Mood and Feelings Questionnaire
• DSRS: Depression Self-Rating Scale
• KADS: Kutcher Adolescent Depression Scale
• PHQ-A: Patient Health Questionnaires-- Adolescent
• SDQ: Strengths and Difficulties Questionnaire
19
SUPPORTIVE MANAGEMENT
-Build rapport
ESTABLISH
SEVERITY -Psycho-education
[clinical -Self-help
assessment -Healthy lifestyle: exercise,
CONDUCT A RISK +depression sleep hygiene
ASSESSMENT rating scale]
-Supportive psychotherapy
(problem solving, stress
management, pleasant events)
ALL PATIENTS
Admission?
20
Depending on severity:
• Watchful waiting
• Supportive management
• Psychosocial interventions
– Cognitive Behavioral Therapy (CBT)
– Interpersonal Psychotherapy (IPT)
• Medication
• Cognitive Behavioral Therapy (CBT)
• Interpersonal Psychotherapy (IPT)
https://www.youtube.com/watch?v=DT6biKxqotw
• Identify links between mood, thoughts,
activities
• Challenge negative thoughts
• Increase enjoyable activities
• Build skills to maintain relationships
• Similar to CBT
• Focus on the present
• Premise=Interpersonal conflicts loss of
social support depression
• Improvement of interpersonal skills
• Psychoeducation about depression
• Increase enjoyable activities
• Strong placebo effect
• Evidence different for adults
• Key aspects for informed consent
• Undertreatment is common
• Most evidence for Selective Serotonin
Reuptake Inhibitors (SSRIs)
– Fluoxetine: approved >8 year olds
– Escitalopram: approved for adolescents in
the US
https://www.youtube.com/watch?v=m4PXHeHqnmE
• Suicidality* • Gastrointestinal
• Manic switch • Weight gain
• Akathisia • Sexual
• Bleeding
• Agitation • Possible congenital
• Irritability • Withdrawal syndrome
• Disinhibition • Serotonin Syndrome
• Nightmares/sleep
disturbances
• Electroconvulsive therapy (ECT): good evidence of
effectiveness in severe cases
• Transcranial Magnetic Stimulation (TMS)
• Light Therapy (in seasonal mood disorder)
• Complementary and Alternative Medicine (CAM)
– St. John’s Wort
– Omega 3 Fatty Acids
– S-Adenosyl Methionine (SAMe)
• Exercise
• Mild: supportive management, CBT, or
IPTno responseCBT, IPT, or antidepressant
medication
• Moderate: supportive management, CBT, IPT
or medication no response–add medication
• Severe: CBT/IPT and medication
• Psychotic depression: CBT/IPT and medication
and second generation antipsychotic drug
• 1st Line: lithium carbonate or quetiapine
• 2nd Line:
--lithium or valproate with an SSRI
--olanzapine and an SSRI, or
--lamotrigine
• No evidence for antidepressants alone
• Lithium and valproate should be avoided in
women of childbearing age
• Two considerations: effectiveness and safety
– SSRIs are safest
– Fluoxetine is most effective
• Begin fluoxetine
– Start with 10mg of fluoxetine
– Increase to 20mg after one week
– 20mg for pre-pubertal children
– 30 or 40mg for adolescents
• If not fluoxetine try another SSRI (e.g., sertraline or
escitalopram)
• Continue treatment 6 months after recovery
• Determining treatment resistance
• Handling treatment resistance
• Possible causes:
– Patient factors
– Family factors
– Environmental factors
– Clinician factors
• Afghanistan
• Japan
• China
• Turkey
• Hispanic populations
• Shortage of child psychiatrists and allied
professionals
• Few training programs
• Stigma
• Few medications
• Minimal inpatient facilities
• Cognitive restructuring
• Social problem-solving
• Interpersonal communication skills
• Coping
• Assertiveness training
American Academy of Child and Adolescent Psychiatry
(AACAP) 2007 Practice Parameter on depressive disorders
http://www.jaacap.com/article/S0890-8567(09)62053-0/pdf